• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Ascendis trial data piles pressure on BioMarin

cafead

Administrator
Staff member
  • cafead   Sep 18, 2024 at 01:52: PM
via Summary study results show Ascendis drug for achondroplasia could be competitive to BioMarin’s Voxzogo, which is the foundation of the latter company’s growth plans.

article source
 

<